Central nervous system lymphoma initially diagnosed as tumefactive multiple sclerosis after brain biopsy

Internal Medicine

Volumn 52, Issue 4, 2013, Pages 483-488

  Ohe, Yasuko ^a   Hayashi, Takeshi ^a   Mishima, Kazuhiko ^a   Nishikawa, Ryo ^a   Sasaki, Atsushi ^b   Matsuda, Hiroshi ^a   Uchino, Akira ^a   Tanahashi, Norio ^a  

^a SAITAMA MEDICAL UNIVERSITY INTERNATIONAL MEDICAL CENTER   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Brain biopsy; Primary central nervous system lymphoma; Tumefactive multiple sclerosis

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CORTICOSTEROID; FLUORODEOXYGLUCOSE F 18; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 2 RECEPTOR; METHYLPREDNISOLONE;

AGED; ARTICLE; ATTENTION DISTURBANCE; BRAIN BIOPSY; BRAIN DAMAGE; CASE REPORT; CELL PROLIFERATION; CYTOLOGY; DEMYELINATING DISEASE; EDEMA; HEMIPARESIS; HISTOPATHOLOGY; HOMONYMOUS HEMIANOPIA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; LIMB WEAKNESS; MALE; MALIGNANT NEOPLASTIC DISEASE; MENTAL DETERIORATION; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA;

AGED; BIOPSY; BRAIN; BRAIN NEOPLASMS; DIAGNOSTIC ERRORS; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MULTIPLE SCLEROSIS;

EID: 84873964877     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.52.8531     Document Type: Article

References (20)

1. Vaquero J, Martinez R, Ross E, et al. Primary cerebral lymphoma: the "ghost tumor" Case report. J Neurosurg 60: 174-176, 1984.
2. Alderson L, Fetell MR, Sisti M, et al. Sentinel lesions of primary CNS lymphoma. J Neurol Neurosurg Psychiatry 60: 102-105, 1996.
3. Suzuki M, Uchiyama T, Takahashi H, et al. A case of primary sentral nervous system lymphoma preceded by cerebral and cere-bellar lesion diminishing spontanepously: Consideration of two brain biopsy at the onset and after two years. Clin Neurol 49: 586-589, 2009.
4. Kuroda Y, Kawasaki T, Haraoka S, et al. Autopsy report of pri-mary CNS B-cell lymphoms indistinguishable from multiple scle-rosis: diagnosis with the immunoglobulin gene rearrangements analysis. J Neurological Sciences 111: 173-179, 1992.
5. Ng S, Butzkueven H, Kalnins R, et al. Prolonged interval between sentinel pseudotumoral demyelination and development of primary CNS lymphoma. J Clin Neuro 14: 1126-1129, 2007.
6. Eby NL, Grufferman S, Flannelly CM, et al. Increasing incidence of primary brain lymphoma in the USA. Cancer 62: 2461-2465, 1988.
7. O'Neill BP, Illig JJ. Primary central nervous system lymphoma. Mayo Clin Proc 64: 1005-1020, 1989.
8. Krumbholz M, Theil D, Derfuss T, et al. BAFF is produced by as-trocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J Exp Med 201: 195-200, 2005.
9. Kuhlmann T, Schroter A, Dechent P, et al. Diagnosis of a multifo-cal B cell lymphoma wiyh preceding demyelinating central nerv-ous system lesions by single voxel proton MR spectroscopy. J Neurol Neurosurg Psychiatry 70: 259-262, 2001.
10. Husseini L, Saleh A, Reifenberger G, et al. Inflammatory demyeli-nating brain lesions heralding primary CNS lymphoma. Can J Neurol Sci 39: 6-10, 2012.
11. Chayasirisobhon S, Kumar V, Ali I, et al. Primary lymphoma of the central nervous system: a diagnostic problem. J Natl Med Assoc 79: 198-200, 1987.
12. Bender PG, Schapiro TR. Primary CNS lymphoma presenting as multiple sclerosis. Minnesota Medicine 72: 157-160, 1989.
13. Rosenfeld SS, Hoffman JM, Coleman RE, et al. Studies of primary central nervous system lymphoma with fluorine-18-fluorodeoxygluose positron emission tomography. J Nucl Med 33: 532-536, 1992.
14. 18F-FDG of common en-hancing malignant brain tumor. Neuroradiology 190: 365-369, 2008.
15. 11C-methionine in 45 positron emission tomography-guided stereotatic brain biopsies. J Neurosurg 101: 476-483, 2004.
16. 11C-methionine PET for dif-ferential diagnosis of low-grade gliomas. Neurology 50: 1316-1322, 1998.
17. 18F-FDG PET. Eur J Nucl Med 29: 176-182, 2002.
18. 11C-methionime positron emission tomography in nontumorous brain lesions. No Shinkei Gaku 38: 985-995, 2010 (in Japanese).
19. Smith ME, Stone LA, Albert PS, et al. Clinical worsening in mul-tiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imag-ing lesions. Ann Neurol 33: 480-489, 1993.
20. McFarland HF, Frank JA, Albert PS, et al. Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis. Ann Neurol 32: 758-766, 1992.